KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Regeneron Pharmaceuticals (REGN) Preferred Shares: 2009

Regeneron Pharmaceuticals' Preferred Shares was N/A to $2,000 in Q4 2009 from the same period last year, while for Dec 2009 it was $2,000, marking a year-over-year change of. This contributed to the annual value of $2,000 for FY2009, which is N/A change from last year.
Regeneron Pharmaceuticals' Preferred Shares amounted to $2,000 in Q4 2009.
Regeneron Pharmaceuticals' 5-year Preferred Shares high stood at $2,000 for Q4 2009, and its period low was $2,000 during Q4 2009.
Moreover, its 1-year median value for Preferred Shares was $2,000 (2009), whereas its average is $2,000.